DHMMF administration was found to significantly suppress the expressions of SREBP1, FASN and SCD1 while concurrently increasing the phosphorylation levels of ACC in both HCC cell lines (Figure 1I,J). The gene discussed is SCD; the disease is hepatocellular carcinoma.